Yes, I listed multiple small wins outside of the US, specifically the Estonia, Germany and the UK. I differentiate between the rest of world and the US because it is not representative of the wider global market and has it's own characteristics that need to be factored in. When swallowing the Kongsberg 20,000 number it's also important to remember that 17-18000 are in the US under the CROWS contract - over a decade ago. A great aftermarket pipeline for sure, but context is everything.
Looking to where they do not have the power of incumbency and an acquisition system that will take the easiest pathway first, ie. the rest of the world, Kongsberg isn't 'blitzing'.
I'm not affirming blue sky representations. I'm simply not agreeing with hyperbole in a post and actually asked for other evidence I've missed. You didn't provide either beyond paraphrasing the competition's website.
- Forums
- ASX - By Stock
- EOS
- Ann: Business Activity Statement & Appendix 4C - Dec-22 Qtr
EOS
electro optic systems holdings limited
Add to My Watchlist
2.26%
!
$2.71

Ann: Business Activity Statement & Appendix 4C - Dec-22 Qtr, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.71 |
Change
0.060(2.26%) |
Mkt cap ! $522.9M |
Open | High | Low | Value | Volume |
$2.68 | $2.78 | $2.67 | $3.647M | 1.341M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 40141 | $2.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40141 | 2.700 |
1 | 10000 | 2.680 |
1 | 5000 | 2.670 |
1 | 70 | 2.660 |
6 | 20598 | 2.650 |
Price($) | Vol. | No. |
---|---|---|
2.740 | 1649 | 2 |
2.750 | 3722 | 3 |
2.770 | 2000 | 1 |
2.780 | 23384 | 7 |
2.790 | 4579 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EOS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online